Novavax shares tumble after U.S. health secretary raises concerns over COVID shot’s efficacy
(Reuters) -Vaccine maker Novavax’s shares plunged over 22% on Thursday after Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns about the company’s COVID-19 vaccine in an interview with CBS News. The U.S. Food and Drug Administration, an agency that is part of the U.S. Department of Health and Human Services, missed its deadline last week for deciding on the traditional approval of the vaccine. The vaccine has been sold under an emergency … Read more…